Learn More
Medchemexpress LLC (2S)-N-[7-chloro-6-[4-[(3R,4R)-4-hydroxy-3-methyloxolan-3-yl]piperazin-1-yl]isoquinolin-3-yl]-6-o... | 2769107-89-1 | 99.7% | 501.02 g·mol⁻1 | C26H33ClN4O4 | 10 MG

Supplier: Medchemexpress LLC HY15642910MG
MK-1468 is an orally active, selective, blood-brain barrier-permeable inhibitor of leucine-rich repeat kinase 2 (LRRK2) used in preclinical research of Parkinson's disease and LRRK2-related pathways.
- Orally active and brain-penetrant LRRK2 inhibitor suitable for in vivo and in vitro studies.
- High purity (≈99.7%) for research-grade experiments.
- Molecular weight 501.02 g·mol⁻1 and formula C26H33ClN4O4.
- Available in small-scale quantities for dosing and assay optimization.
- Store powder at -20°C; solutions stable at -80°C for 6 months.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.